Navigation Links
Abbott to Present Data on Novel Cancer Treatments at American Society of Clinical Oncology Annual Meeting
Date:5/15/2008

3.5 hours. In seven out of 20 cases (35 percent), DP-PS correctly predicted the eventual outcome. These results seem to indicate that PS derived from DP model showed better correlation with drug exposure and could predict patient outcome better than Ktrans.

In a separate analysis, the effects of ABT-869 on biomarkers of angiogenesis were evaluated. Correlations of dose and pharmacokinetics of ABT-869, with serum biomarkers, tumor DCE-MRI tracer kinetics, proteinuria and hypertension were assessed. Results appeared to indicate that ABT-869 induced dose-dependent changes in serum biomarkers are consistent with anti-angiogenic activity. However, these serum biomarkers had limited value in predicting safety, i.e., proteinuria or hypertension. The utility of tumor flow and permeability changes on DCE-MRI in predicting proteinuria should be further examined. Updated information will be presented at the ASCO Annual Meeting.

Background on Abbott's Oncology Pipeline

Bcl-2 Family Protein Inhibitors (ABT-263)

Researchers have been interested in the Bcl-2 family of proteins since their role in preventing apoptosis -- the natural process by which damaged or unwanted cells die and are cleared from the body -- was proven more than a decade ago. Discovered by Abbott scientists, ABT-263 restores programmed cell death, a natural mechanism for the elimination of cancerous cells, by inhibiting the function of Bcl-2 proteins.

Bcl-2 proteins play a central role in regulating apoptosis, as well as tumor formation, tumor growth and resistance to treatment. Pioneering work in structural biology at Abbott established how the Bcl-2 family proteins interact with one another, leading researchers to develop a novel compound that causes cancer cells to self-destruct.

ABT-263 is in Phase I/II clinical trials for lymphomas and solid tumors, including small cell lung cancer. Preclinical data has shown that Abbott's Bcl-2 family protein inhibitors bind to Bc
'/>"/>

SOURCE Abbott
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine news :

1. Abbott to Present at Citi Investment Research Global Health Care Conference
2. Abbott to Present at Morgan Stanley Global Healthcare Unplugged Conference
3. Abbott Announces HUMIRA(R) (adalimumab) Approved in Japan for the Treatment of Rheumatoid Arthritis
4. Abbott Reports Double-Digit Sales and Earnings Growth in First Quarter and Reaffirms Full-Year Growth Outlook
5. Innovative Diagnostic Instrument Introduced by Abbott for Low- to Mid-Volume Laboratory Market Segment
6. Abbott FreeStyle Freedom(R) Lite Blood Glucose Monitoring System Now Available With No Coding for People With Diabetes
7. Abbott Hosts Conference Call for First-Quarter Earnings
8. Takeda, Abbott Announce Plans to Conclude TAP Joint Venture
9. FDA Approves Abbotts FreeStyle Navigator(R) Continuous Glucose Monitoring System
10. Abbott Receives CE Mark for Smaller-Size XIENCE(TM) V Drug Eluting Stent
11. Abbott, Genentech and WEHI Collaborate to Research and Develop New Anti-Cancer Drugs
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/20/2014)... New York (PRWEB) December 20, 2014 ... continue to move forward in U.S. courts, Bernstein ... study which suggests that children treated with the ... hormone linked to breast development and lactation. The ... at 34 children and adolescents who began treatment ...
(Date:12/20/2014)... Recently, AngelWeddingDress.com has introduced its special offer (called the ... In the promotion, all buyers worldwide can enjoy a ... special for the women who are looking for inspired, ... collections of 2015 dresses have been unveiled recently. All ... prices. Visit our website now before they are out ...
(Date:12/20/2014)... The Twin Cities DI Day is ... the nation! Over 250 financial professionals come together each ... the industry, get motivated to protect their clients and ... and overcoming the challenges of disability. , On September ... came together to attend The 13th Annual Twin Cities ...
(Date:12/19/2014)... Today, Balfleet.com , a leading ... its formal dress promotion. All the old and new ... off. , Balfleet.com is well-known for its high quality ... dresses, cocktail dresses and more. Its formal dresses are ... and they can create an elegant look when paired ...
(Date:12/19/2014)... Sub Zero Ice Cream is partnering up with ... the 28th from 2pm-6pm at the Expo Center on the ... FL. , Inquiries regarding time slots and signing up, email ... donating process, Sub Zero Ice Cream & Yogurt will be ... , About Sub Zero Ice Cream & Yogurt , ...
Breaking Medicine News(10 mins):Health News:Risperdal Lawsuit News: Bernstein Liebhard LLP Notes Publication of Study Suggesting Medication May Raise Prolactin Levels in Children 2Health News:Risperdal Lawsuit News: Bernstein Liebhard LLP Notes Publication of Study Suggesting Medication May Raise Prolactin Levels in Children 3Health News:Risperdal Lawsuit News: Bernstein Liebhard LLP Notes Publication of Study Suggesting Medication May Raise Prolactin Levels in Children 4Health News:AngelWeddingDress Has Introduced Its Special Offer For The Coming Christmas 2Health News:The 13th Annual Twin Cities DI Day Now On Video 2Health News:The 13th Annual Twin Cities DI Day Now On Video 3Health News:Balfleet.com Announces Its Formal Dress Promotion For 2015 2Health News:Shark Tank’s Sub Zero Ice Cream Sponsors Blood Drive 2
... by Professor Richard Hayes at the London School of ... to test an innovative combination of strategies to prevent ... ART (PopART), will test the impact of a combination ... HIV, offer of medical circumcision to men who test ...
... symposium will provide information to educate physicians, psychiatrists ... the possibility of neurological repercussions to post-infectious syndromes. ... known about the cause and effect relationship between ... this symposium will raise the medical community,s awareness ...
... (HealthDay News) -- The facts about cancer found on ... information on the disease found on the patient-oriented section ... (PDQ), a comprehensive peer-reviewed cancer database, according to a ... University were hard-pressed to find errors on Wikipedia, they ...
... By Steven Reinberg HealthDay Reporter , THURSDAY, Sept. ... will begin earlier this year, so seniors need to ... they want in 2012, U.S. health officials said Thursday. ... the same for the 99.7 percent of Medicare recipients who ...
... A new study suggests that blocking cancer cells, access ... glioblastoma, the most common and deadly form of brain ... be appropriate for tumors with a hyperactive PI3K signaling ... glioblastomas cases. , Researchers at the Ohio State University ...
... rare but often deadly disease that can strike at any ... women and in the past was referred to as a ... with ovarian cancer that can assist in early detection. Experts ... use of preventive methods, understand the risks and recognize potential ...
Cached Medicine News:Health News:Major grant awarded for HIV prevention study in Africa 2Health News:Major grant awarded for HIV prevention study in Africa 3Health News:Wikipedia Accurate on Cancer Facts, But Hard to Read: Study 2Health News:Enrollment Period for Medicare Starts Early This Year 2Health News:Starving cancer cells of cholesterol might offer a new way to treat brain tumors 2Health News:Early detection is key in the fight against ovarian cancer 2Health News:Early detection is key in the fight against ovarian cancer 3
(Date:12/17/2014)... -- Los beneficios y ganancias están por ... gasto en investigación y desarrollo   En ... septiembre de 2014) ZEISS aumentó sus ingresos en un ... anterior: 4.190 millones de euros) a pesar de los ... un 14 por ciento, a 360 millones de euros. ...
(Date:12/17/2014)... 2014  Strategic Health Services, Inc. (SHS), a leading ... a strategic agreement with QualCare, Inc., a leading provider of ... regional marketplace.  This agreement will further QualCare,s population ... solutions QualCare brings to its clients in ... QualCare plans cover more than 800,000 member ...
(Date:12/17/2014)... Dec. 17, 2014 With advancements in ... MRI market is seeing new growth, according to ... scans account for the majority of market volume, ... of images, which are creating opportunities for more sophisticated ... is growing at a rate of 4%, with ...
Breaking Medicine Technology:ZEISS confirma su posición en un entorno difícil 2Strategic Health Services to collaborate with QualCare on Population Health and Wellness Technology for QualCare Members 2Strategic Health Services to collaborate with QualCare on Population Health and Wellness Technology for QualCare Members 3Kalorama: 3T Advancements Bringing New Growth to the MRI Market 2Kalorama: 3T Advancements Bringing New Growth to the MRI Market 3
... 2010 Bayer HealthCare Pharmaceuticals, Inc. today announced the ... new oral contraceptive (OC), SAFYRAL™ (drospirenone 3 mg/ ethinyl ... levomefolate calcium 451 mcg tablets).  In women who choose ... for the purpose of reducing the risk of rare ...
... LAS VEGAS, Dec. 16, 2010 American Pacific Corporation (Nasdaq: ... fiscal 2010 year and fourth quarter ended September 30, 2010. ... to financial results based on GAAP.  A reconciliation of the ... included in the accompanying supplemental data. ...
Cached Medicine Technology:U.S. FDA Approves Second Bayer Oral Contraceptive That Also Raises Folate Levels 2U.S. FDA Approves Second Bayer Oral Contraceptive That Also Raises Folate Levels 3U.S. FDA Approves Second Bayer Oral Contraceptive That Also Raises Folate Levels 4U.S. FDA Approves Second Bayer Oral Contraceptive That Also Raises Folate Levels 5U.S. FDA Approves Second Bayer Oral Contraceptive That Also Raises Folate Levels 6U.S. FDA Approves Second Bayer Oral Contraceptive That Also Raises Folate Levels 7U.S. FDA Approves Second Bayer Oral Contraceptive That Also Raises Folate Levels 8American Pacific Reports Fiscal 2010 Results 2American Pacific Reports Fiscal 2010 Results 3American Pacific Reports Fiscal 2010 Results 4American Pacific Reports Fiscal 2010 Results 5American Pacific Reports Fiscal 2010 Results 6American Pacific Reports Fiscal 2010 Results 7American Pacific Reports Fiscal 2010 Results 8American Pacific Reports Fiscal 2010 Results 9American Pacific Reports Fiscal 2010 Results 10American Pacific Reports Fiscal 2010 Results 11American Pacific Reports Fiscal 2010 Results 12American Pacific Reports Fiscal 2010 Results 13American Pacific Reports Fiscal 2010 Results 14American Pacific Reports Fiscal 2010 Results 15American Pacific Reports Fiscal 2010 Results 16American Pacific Reports Fiscal 2010 Results 17American Pacific Reports Fiscal 2010 Results 18American Pacific Reports Fiscal 2010 Results 19American Pacific Reports Fiscal 2010 Results 20American Pacific Reports Fiscal 2010 Results 21American Pacific Reports Fiscal 2010 Results 22American Pacific Reports Fiscal 2010 Results 23
... The ROYAL™ single-use skin stapler places one ... The staples first penetrate the skin and are ... skin staples are available in two sizes: wide ... closure) and regular (having a clip span of ...
... CONCORDE staplers place one staple ... are activated. The staples first ... then formed, thus holding the ... staple sizes, each contained in ...
... PROXIMATE Skin Staplers place single ... are made of lubricant-coated stainless steel; ... Endo-Surgery makes three different skin staplers ... skin stapler has applications for routine ...
... articulating (22° and 45° in both directions) ... resection, transection and anastomosis for open surgery ... two triple-staggered rows of staples and simultaneously ... The instrument is designed for multiple use ...
Medicine Products: